Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lund

Showing results (261-270 of 435) with videos related to

Pageof 44
Sort By:
Journal of Geriatric Oncology|November 16, 2021
Patterns of first-line targeted therapy utilization and adherence among older adults diagnosed with metastatic renal cell carcinomaBlánaid M Hicks, Danielle S Chun, Sharon Peacock Hinton, et al.
Pharmacoepidemiology and Drug Safety|April 1, 2024
Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative dataJoshua D Niznik, Shahar Shmuel, Virginia Pate, et al.
Nutrients|May 27, 2023
In Vitro Screening for Probiotic Properties of <i>Lactobacillus</i> and <i>Bifidobacterium</i> Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease PreventionSilvia Lopez-Escalera, Mari L Lund, Gerben D A Hermes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2022
Adverse Urinary System Outcomes among Older Women with Endometrial CancerC Anderson, J L Lund, J Park, et al.
Human Molecular Genetics|October 1, 1993
A zinc-finger gene ZNF141 mapping at 4p16.3/D4S90 is a candidate gene for the Wolf-Hirschhorn (4p-) syndromeN Tommerup, L Aagaard, C L Lund, et al.
Clinical Epidemiology|December 5, 2017
Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleedingJennifer L Lund, Erzsébet Horváth-Puhó, Szimonetta Komjáthiné Szépligeti, et al.
The Oncologist|March 18, 2020
Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic CancerRobert W Corty, Benjamin W Langworthy, Jason P Fine, et al.
Epidemiology (Cambridge, Mass.)|April 7, 2020
Integrating Surveillance Data to Estimate Race/Ethnicity-specific Hysterectomy Inequalities Among Reproductive-aged Women: Who's at Risk?Danielle R Gartner, Paul L Delamater, Robert A Hummer, et al.
The American Journal of Gastroenterology|December 3, 2024
Correction to: Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel DiseaseJeff Y Yang, Jennifer L Lund, Michele Jonsson Funk, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 19, 2011
Risk-benefit trade-offs in revascularisation choicesJerome J Federspiel, Sally C Stearns, Ron T van Domburg, et al.
Pageof 44

Showing results (261-270 of 435) with videos related to

Sort By:
Pageof 44
Journal of Geriatric Oncology|November 16, 2021
Patterns of first-line targeted therapy utilization and adherence among older adults diagnosed with metastatic renal cell carcinomaBlánaid M Hicks, Danielle S Chun, Sharon Peacock Hinton, et al.
Pharmacoepidemiology and Drug Safety|April 1, 2024
Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative dataJoshua D Niznik, Shahar Shmuel, Virginia Pate, et al.
Nutrients|May 27, 2023
In Vitro Screening for Probiotic Properties of <i>Lactobacillus</i> and <i>Bifidobacterium</i> Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease PreventionSilvia Lopez-Escalera, Mari L Lund, Gerben D A Hermes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2022
Adverse Urinary System Outcomes among Older Women with Endometrial CancerC Anderson, J L Lund, J Park, et al.
Human Molecular Genetics|October 1, 1993
A zinc-finger gene ZNF141 mapping at 4p16.3/D4S90 is a candidate gene for the Wolf-Hirschhorn (4p-) syndromeN Tommerup, L Aagaard, C L Lund, et al.
Clinical Epidemiology|December 5, 2017
Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleedingJennifer L Lund, Erzsébet Horváth-Puhó, Szimonetta Komjáthiné Szépligeti, et al.
The Oncologist|March 18, 2020
Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic CancerRobert W Corty, Benjamin W Langworthy, Jason P Fine, et al.
Epidemiology (Cambridge, Mass.)|April 7, 2020
Integrating Surveillance Data to Estimate Race/Ethnicity-specific Hysterectomy Inequalities Among Reproductive-aged Women: Who's at Risk?Danielle R Gartner, Paul L Delamater, Robert A Hummer, et al.
The American Journal of Gastroenterology|December 3, 2024
Correction to: Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel DiseaseJeff Y Yang, Jennifer L Lund, Michele Jonsson Funk, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 19, 2011
Risk-benefit trade-offs in revascularisation choicesJerome J Federspiel, Sally C Stearns, Ron T van Domburg, et al.
Pageof 44